Claudia I. Henschke

Claudia I. Henschke

Auto-generated profile, based on publicly available information

Claudia I. Henschke

Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2010 in Radiology
Verified
Journal Article
Closed access
JSJoseph Shemesh
Joseph Shemesh
CHClaudia I. Henschke
Claudia I. Henschke
DSDorith Shaham
Dorith Shaham
RYRowena Yip
Rowena Yip
AFAli O. Farooqi
Ali O. Farooqi
DYDavid F. Yankelevitz
David F. Yankelevitz
The main finding of this study is that the coronary artery calcification (CAC) score as generated from an ungated low-dose CT scan of the chest provides prognostic information regarding cardiovascular death even when adjusted for age and smoking history; moderate and large amounts of CAC were highly associated with a significant increase in cardiovascular death. PurposeTo assess the usefulness of ordinal scoring of the visual assessment of coronary artery calcification (CAC) on low-dose computed tomographic (CT) scans of the chest in the prediction of cardiovascular death.Materials and MethodsAll participants consented to low-dose CT screening according to an institutional review board–approved protocol. The amount of CAC was assessed on ungated low-dose CT scans of the chest obtained between June 2000 and December 2005 in a cohort of 8782 smokers aged 40–85 years. The four main coronary arteries were visually scored, and each participant received a CAC score of 0–12. The date and cause of death was obtained by using the National Death Index. Follow-up time (median, 72.3 months; range, 0.3–91.9 months) was calculated as the time between CT and death, loss to follow-up, or December 31, 2007, whichever came first. Logistic regression analysis was used to determine the risk of mortality according to CAC category adjusted for age, pack-years of cigarette smoking, and...

1 February 2014 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
NANasser K. Altorki
Nasser K. Altorki
RYRowena Yip
Rowena Yip
THTakaomi Hanaoka
Takaomi Hanaoka
TBThomas Bauer
Thomas Bauer
RARalph Aye
Ralph Aye
CHClaudia I. Henschke
Claudia I. Henschke

1 November 2015 in Radiology
Verified
Journal Article
Closed access
DYDavid F. Yankelevitz
David F. Yankelevitz
RYRowena Yip
Rowena Yip
JSJames P. Smith
James P. Smith
MLMingzhu Liang
Mingzhu Liang
YLYing Liu
Ying Liu
AGAs the Writing Committee for The International Early Lung Cancer Action Program Investigators Group
As the Writing Committee for The International Early Lung Cancer Action Program Investigators Group
Our recommendation of 1-year follow-up is based on the knowledge that lung cancers manifesting as nonsolid nodules have slow growth rates, that all were stage I adenocarcinomas, and that survival was 100% despite substantial time between the initial identification and treatment. Purpose To address the frequency of identifying nonsolid nodules, diagnosing lung cancer manifesting as such nodules, and the long-term outcome after treatment in a prospective cohort, the International Early Lung Cancer Action Program. Materials and Methods A total of 57 496 participants underwent baseline and subsequent annual repeat computed tomographic (CT) screenings according to an institutional review board, HIPAA-compliant protocol. Informed consent was obtained. The frequency of participants with nonsolid nodules, the course of the nodule at follow-up, and the resulting diagnoses of lung cancer, treatment, and outcome are given separately for baseline and annual repeat rounds of screening. The χ2 statistic was used to compare percentages. Results A nonsolid nodule was identified in 2392 (4.2%) of 57 496 baseline screenings, and pathologic pursuit led to the diagnosis of 73 cases of adenocarcinoma. A new nonsolid nodule was identified in 485 (0.7%) of 64 677 annual repeat screenings, and 11 had a ...

19 February 2013 in Annals of Internal Medicine
Verified
Journal Article
Closed access
PDF file
CHClaudia I. Henschke
Claudia I. Henschke
RYRowena Yip
Rowena Yip
DYDavid F. Yankelevitz
David F. Yankelevitz
JSJames P. Smith
James P. Smith
FIfor the International Early Lung Cancer Action Program Investigators*
for the International Early Lung Cancer Action Program Investigators*
Chinese translation Low-dose computed tomography screening for lung cancer can reduce mortality among high-risk persons, but “false-positive” findings may result in unnecessary evaluations with attendant risks. The effect of alternative thresholds for defining a positive result on the rates of positive results and cancer diagnoses is unknown. To assess the frequency of positive results and potential delays in diagnosis in the baseline round of screening by using more restrictive thresholds. Prospective cohort study. Multi-institutional International Early Lung Cancer Action Program. 21 136 participants with baseline computed tomography performed between 2006 and 2010. The frequency of solid and part-solid pulmonary nodules and the rate of lung cancer diagnosis by using current (5 mm) and more restrictive thresholds of nodule diameter. The frequency of positive results in the baseline round by using the current definition of positive result (any parenchymal, solid or part-solid, noncalcified nodule ≥5.0 mm) was 16% (3396/21 136). When alternative threshold values of 6.0, 7.0, 8.0 and 9.0 mm were used, the frequencies of positive results were 10.2% (95% CI, 9.8% to 10.6%), 7.1% (CI, 6.7% to 7.4%), 5.1% (CI, 4.8% to 5.4%), and 4.0% (CI, 3.7% to 4.2%), respectively. Use of these alternative definitions would have reduced the work-up by 36%, 56%, 68%, and 75%, respectively. Concomitantly, lung cancer diagnostics would have been delayed by at most 9 months for 0%, 5.0% (CI, 1.1% to 9.0%), 5.9% (CI, 1.7 to 10.1%), and 6.7% (CI, 2.2% to 11.2%) of the cases of cancer, respectively. This was a retrospective analysis and thus whether delays in diagnosis would have altered outcomes cannot be determined. These findings suggest that using a threshold of 7 or 8 mm to define positive results in the baseline round of computed tomography screening for lung cancer should be prospectively evaluated to determine whether the benefits of decreasing further work-up outweigh the consequent delay in diagnosis in some patients. The Flight Attendant Medical Research Institute and the American Legacy Foundation.

1 May 2012 in Chest
Verified
Journal Article
Closed access
JZJavier J. Zulueta
Javier J. Zulueta
JWJuan P. Wisnivesky
Juan P. Wisnivesky
CHClaudia I. Henschke
Claudia I. Henschke
RYRowena Yip
Rowena Yip
AFAli O. Farooqi
Ali O. Farooqi
DYDavid F. Yankelevitz
David F. Yankelevitz

1 November 2014 in Radiology
Verified
Journal Article
Closed access
RYRowena Yip
Rowena Yip
CHClaudia I. Henschke
Claudia I. Henschke
DYDavid F. Yankelevitz
David F. Yankelevitz
JSJames P. Smith
James P. Smith
In a high-risk population, such as that of the National Lung Screening Trial (NLST), an increase in the average nodule-diameter threshold from 5.0 mm to 6.0, 7.0, 8.0, and 9.0 mm would decrease the obtaining of an additional CT scan of the chest by 33.8%, 54.7%, 66.6%, and 73.8%, respectively, and result in a delay in the diagnosis of lung cancer of 0.9%, 2.6%, 6.0%, and 9.9% of patients who actually received a diagnosis of lung cancer during the baseline round of the NLST CT arm. PurposeTo determine the usefulness of alternative nodule size thresholds in a population undergoing computed tomographic (CT) screening for lung cancer and to compare the reported International Early Lung Cancer Action Program (I-ELCAPInternational Early Lung Cancer Action Program) results with the National Lung Screening Trial (NLSTNational Lung Screening Trial) results.Materials and MethodsThe institutional review board approved this retrospective analysis. Informed consent was obtained according to HIPAA compliance. Findings in the CT cohort in the NLSTNational Lung Screening Trial of 25 813 participants who underwent baseline CT in 2002–2004 were reviewed. The frequency of solid and part-solid pulmonary nodules and the lung cancer diagnoses using an alternative nodule threshold of 5.0, 6.0, 7.0, 8.0, and 9.0 mm were determined. Proportional reduction in the frequency of positive results and their 95% confidence intervals using each of the alternative thresholds were calculated.ResultsThe frequency of ...